|
Market Cap | 1.35B | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 68.53% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.29% | Earnings | May 16/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 881.74K | 52W Range | 18.50 - 20.15 |
|
|
|
Marex Group Plc provides brokerage services for commodities, financials, and foreign exchange. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The Clearing segment allows the clients access to exchanges and clearing houses. The Agency and Execution segment match buyers and sellers on an agency basis by facilitating price discovery of commodities and financial markets. The Market Making segment offers direct market pricing to professional and wholesale counterparties in a variety of commodity and securities markets. The company was founded by Mark Slade in 2005 and is headquartered in London, the United Kingdom. |
|
|
|
Market Cap | 3.37M | EPS (ttm) | -25.72 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 49.60% |
P/S | 0.36 | EPS next 5Y | - |
P/B | 0.11 | EPS Q/Q | -12.38% |
Dividend | - | Sales Q/Q | 314.44% |
Insider Own | 28.35% | Inst Own | 8.32% |
Insider Trans | -2.52% | Inst Trans | - |
Short Float | 6.42% | Earnings | May 16/b |
Analyst Recom | 1.00 | Target Price | 12.00 |
Avg Volume | 72.70K | 52W Range | 2.88 - 21.92 |
|
|
|
My Size, Inc. engages in the development of measurement technologies. It provides solutions for e-commerce, apparel, shipping and parcel delivery, and do-it-yourself industry applications. The firm offers measurement apps including MySizeID, BoxSize, and SizeUP. The company was founded by Ronen Luzon on September 20, 1999 and is headquartered in Airport City, Israel. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Luzon Ronen | Chief Executive Officer | Nov 29 '23 | Sale | 0.68 | 4,683 | 3,202 | 100,000 | Dec 04 04:15 PM | Turchinsky Ilia | Former CTO | Sep 06 '23 | Sale | 1.41 | 1,211 | 1,708 | 12,776 | Sep 13 04:15 PM | Turchinsky Ilia | Former CTO | Aug 24 '23 | Sale | 2.47 | 2,013 | 4,972 | 13,987 | Aug 31 04:15 PM |
|
|
|
|
Market Cap | 12.49B | EPS (ttm) | 5.55 |
P/E | 35.80 | EPS this Y | 20.85% |
Forward P/E | 16.41 | EPS next Y | 13.94% |
PEG | 2.63 | EPS past 5Y | 14.49% |
P/S | 5.07 | EPS next 5Y | 13.62% |
P/B | 3.74 | EPS Q/Q | 38.62% |
Dividend | 0.01% | Sales Q/Q | 15.29% |
Insider Own | 0.20% | Inst Own | 67.46% |
Insider Trans | 0.00% | Inst Trans | -0.35% |
Short Float | 4.06% | Earnings | May 16/b |
Analyst Recom | 1.12 | Target Price | 301.40 |
Avg Volume | 394.48K | 52W Range | 149.54 - 270.73 |
|
|
|
NICE Ltd. engages in the provision of enterprise software solutions and services. It operates through the following segments: Customer Engagement, and Financial Crime and Compliance Solutions. The Customer Engagement segment provides suites such as compliance and risk, workforce optimization, operational efficiency, customer experience, and sales and retention. The Financial Crime and Compliance Solutions segment includes for enterprise risk management, anti-money laundering, fraud prevention, and brokerage compliance services. The company was founded on September 28, 1986 and is headquartered in Raanana, Israel. |
|
| |
|
Market Cap | 5.86M | EPS (ttm) | -5.12 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.08 | EPS next 5Y | - |
P/B | 1.49 | EPS Q/Q | 101.80% |
Dividend | - | Sales Q/Q | -39.46% |
Insider Own | 20.70% | Inst Own | 1.31% |
Insider Trans | 0.00% | Inst Trans | -8.80% |
Short Float | 2.58% | Earnings | May 16/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 142.88K | 52W Range | 0.43 - 2.44 |
|
|
|
Eightco Holdings, Inc. is a publicly traded holding company that operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology and capital solutions to empower small to medium-sized businesses. It executes this mission by investing in its subsidiaries, Forever 8 and Ferguson Containers, helping them drive production innovation and expansion into new and exciting markets. The company was founded in 1966 and is headquartered in Easton, PA. |
|
|
|
Market Cap | 170.79M | EPS (ttm) | -11.48 |
P/E | - | EPS this Y | 11.07% |
Forward P/E | - | EPS next Y | 51.35% |
PEG | - | EPS past 5Y | 52.49% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -1444.33% |
Dividend | - | Sales Q/Q | - |
Insider Own | 29.33% | Inst Own | 32.39% |
Insider Trans | 0.95% | Inst Trans | -24.34% |
Short Float | 7.64% | Earnings | May 16/b |
Analyst Recom | 1.14 | Target Price | 39.86 |
Avg Volume | 680.36K | 52W Range | 4.00 - 40.60 |
|
|
|
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Haddadin Yezan Munther | Director | Mar 28 '24 | Buy | 11.82 | 1,882 | 22,242 | 5,049 | Mar 29 10:39 AM | Evanson Jeff | CHIEF COMMERCIAL OFFICER | Mar 07 '24 | Buy | 0.42 | 62,484 | 26,243 | 808,459 | Mar 11 04:43 PM |
|
|
| |
|
Market Cap | 412.54M | EPS (ttm) | -3.31 |
P/E | - | EPS this Y | 1.77% |
Forward P/E | - | EPS next Y | 8.89% |
PEG | - | EPS past 5Y | -19.52% |
P/S | - | EPS next 5Y | - |
P/B | 1.10 | EPS Q/Q | -3.22% |
Dividend | - | Sales Q/Q | - |
Insider Own | 27.59% | Inst Own | 91.54% |
Insider Trans | -0.07% | Inst Trans | -0.78% |
Short Float | 19.05% | Earnings | May 16/b |
Analyst Recom | 1.10 | Target Price | 13.40 |
Avg Volume | 984.04K | 52W Range | 5.86 - 24.81 |
|
|
|
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Xynos Konstantinos | Chief Medical Officer | Nov 16 '23 | Sale | 10.92 | 7,313 | 79,858 | 112,714 | Nov 17 08:01 PM | Sarchi Christopher | Chief Commercial Officer | Nov 16 '23 | Sale | 10.92 | 5,255 | 57,385 | 72,245 | Nov 17 08:00 PM | Esposito Pamela | Chief Business Officer | Sep 12 '23 | Option Exercise | 3.30 | 300 | 990 | 263,736 | Sep 13 09:02 PM | Esposito Pamela | Chief Business Officer | Sep 12 '23 | Sale | 20.00 | 300 | 6,000 | 263,436 | Sep 13 09:02 PM | Esposito Pamela | Chief Business Officer | Sep 11 '23 | Option Exercise | 3.30 | 5,358 | 17,681 | 268,794 | Sep 13 09:02 PM |
|
|
|
|
Market Cap | 14.76M | EPS (ttm) | -0.18 |
P/E | - | EPS this Y | 36.36% |
Forward P/E | 3.80 | EPS next Y | 153.57% |
PEG | - | EPS past 5Y | 25.76% |
P/S | 0.02 | EPS next 5Y | - |
P/B | 0.58 | EPS Q/Q | 82.60% |
Dividend | - | Sales Q/Q | -49.32% |
Insider Own | 37.38% | Inst Own | 12.21% |
Insider Trans | 0.23% | Inst Trans | -3.79% |
Short Float | 0.12% | Earnings | May 16/b |
Analyst Recom | 3.00 | Target Price | 3.50 |
Avg Volume | 181.52K | 52W Range | 0.22 - 1.47 |
|
|
|
Sadot Group, Inc. operates as a restaurant chain business. It operates through the following segments: Muscle Maker Grill Restaurant, Pokemoto Hawaiian Poke Restaurant, Non-Traditional (Hybrid), SuperFit Foods Meal Prep, and Sadot. The firm offers protein based meals featuring chicken, seafood, pasta, hamburgers, wraps and flat breads. It also provides salads, protein shakes and fruit smoothies. The company was founded by Rodney C. Silva in 1995 and is headquartered in Fort Worth, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Errington David | Director | Dec 12 '23 | Buy | 0.40 | 10,000 | 3,986 | 30,156 | Dec 12 03:41 PM | Black Jennifer Kay | Chief Financial Officer | Nov 30 '23 | Buy | 0.52 | 10,000 | 5,200 | 60,800 | Dec 01 09:39 AM | Errington David | Director | Nov 27 '23 | Buy | 0.58 | 16,946 | 9,829 | 20,156 | Nov 28 10:12 AM | Errington David | Director | Nov 24 '23 | Buy | 0.57 | 54 | 31 | 3,210 | Nov 28 10:12 AM | Miller Kenneth Eugene | Chief Operating Officer | Nov 17 '23 | Buy | 0.49 | 5,700 | 2,793 | 42,142 | Nov 17 02:44 PM |
|
|
| |
|
Market Cap | 1.96B | EPS (ttm) | -0.14 |
P/E | - | EPS this Y | 279.91% |
Forward P/E | 9.81 | EPS next Y | 259.43% |
PEG | - | EPS past 5Y | -8.01% |
P/S | 11.42 | EPS next 5Y | - |
P/B | 13.07 | EPS Q/Q | 70.93% |
Dividend | - | Sales Q/Q | - |
Insider Own | 58.69% | Inst Own | 30.10% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 22.25% | Earnings | May 16/b |
Analyst Recom | 1.20 | Target Price | 31.02 |
Avg Volume | 1.13M | 52W Range | 10.46 - 43.18 |
|
|
|
Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil. |
|
|
|
Market Cap | 908.88M | EPS (ttm) | -1.44 |
P/E | - | EPS this Y | 6.91% |
Forward P/E | - | EPS next Y | 0.28% |
PEG | - | EPS past 5Y | -6.72% |
P/S | 28.98 | EPS next 5Y | - |
P/B | 41.81 | EPS Q/Q | -0.47% |
Dividend | - | Sales Q/Q | -53.41% |
Insider Own | 8.80% | Inst Own | 52.14% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.82% | Earnings | May 16/b |
Analyst Recom | 1.00 | Target Price | 57.75 |
Avg Volume | 199.73K | 52W Range | 4.84 - 27.72 |
|
|
|
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom. |
|
|
|
Market Cap | 75.28M | EPS (ttm) | - |
P/E | - | EPS this Y | -36.80% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -41.82% |
Dividend | 0.57% | Sales Q/Q | 4.44% |
Insider Own | - | Inst Own | 0.00% |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | May 16/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 223.67K | 52W Range | 1.46 - 8.74 |
|
|
|
SYLA Technologies Co., Ltd. engages in the operation of property investment platform. Its asset management platform includes Rimawari-kun and Rimawari-kun Pro. Rimawari-kun targets individual, in which this platform to facilitate real estate crowdfunding as well as the purchase and sale of real estate, sale of solar power plants which it constructs, and sale of computers. Rimawari-kun Pro targets corporate investors, institutional investors, and high-net-worth individuals. It exhibits properties on this platform as well as wide range of properties from other companies. Its business also includes asset management, including leasing, brokerage, and management of real estate, and operation and maintenance of solar power plants. The company was founded on March 3, 2009 and is headquartered in Tokyo, Japan. |
|
|